News

Preliminary Data from Two Clinical Trials with ADC Candidates were Presented Orally at the 2025 ASCO Annual Meeting
ASCO Annual Meeting is taking place in Chicago, US, from May 30 to June 3. Duality Bio (HKEX: 9606.HK) presented the ...
Acerand Therapeutics Initiates First-in-Human Phase I Clinical Trial of ACE-232, a Novel CYP11A1 Inhibitor for Advanced Prostate Cancer
Acerand Therapeutics, a clinical-stage biotech company focusing on the discovery and development of innovative small-molecule ...
BMJ12d
Optimal dose and type of physical activity to improve functional capacity and minimise adverse events in acutely hospitalised older adults: a systematic review with dose ...
Using novel meta-analytical techniques (ie, model-based dose-response network meta-analysis under a Bayesian framework) and evidence from existing randomised controlled trials ... physical activity ...